Related Experiment Video
Updated: Jun 2, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters
Jing Zhang1, Geralyn Lambert-Messerlian, Glenn E Palomaki
1Department of Pathology and Laboratory Medicine, Women and Infants Hospital and Alpert Medical School of Brown University, Providence, RI 02903, USA.
Insights
Smoking significantly alters prenatal screening markers. Pregnant smokers show increased Down syndrome and trisomy 18 screen positive rates, particularly with combined and integrated tests.
Area of Science:
- Prenatal screening
- Maternal health
- Genetic disorder risk assessment
Background:
- Smoking during pregnancy is a known health risk.
- Its impact on specific prenatal screening markers requires detailed examination.
- Understanding these effects is crucial for accurate risk assessment.
Purpose of the Study:
- To investigate how smoking affects first and second trimester screening markers.
- To determine the impact of these smoking-induced changes on Down syndrome and trisomy 18 risk calculations.
- To evaluate these effects across different screening test types: first trimester combined, second trimester quadruple, and integrated tests.
Main Methods:
- Retrospective analysis of screening records from 2006-2008.
- Extraction of first and second trimester marker values (PAPP-A, hCG, nuchal translucency, AFP, uE3, inhibin A) as multiples of the median (MoM).
- Correlation of marker levels with smoking status, demographic data, and calculated risk results for chromosomal abnormalities.
Main Results:
- Smoking reduced median levels of first trimester PAPP-A and hCG, and second trimester uE3 and hCG.
- Smoking increased levels of second trimester AFP and inhibin A.
- Smokers exhibited higher Down syndrome screen positive rates with the second trimester quadruple test and increased trisomy 18 screen positive rates with first trimester combined or integrated tests.
Conclusions:
- Smoking significantly alters key prenatal screening markers.
- These alterations lead to increased screen positive rates for Down syndrome and trisomy 18.
- The impact is particularly notable for trisomy 18 when using first trimester combined or integrated screening approaches.
Objectives:
To examine the effects of smoking on first and second trimester screening markers and to determine the overall impact of these effects on Down syndrome and trisomy 18 risks in first trimester combined, second trimester quadruple and integrated tests.
Methods:
Examination of screening records at Women and Infants Hospital during 2006-2008. First trimester pregnancy-associated plasma protein-A (PAPP-A), beta-human chorionic gonadotrophin (hCG) and nuchal translucency and second trimester alpha-fetoprotein (AFP), unconjugated estriol (uE3), hCG and inhibin A (inhA) multiple of the median (MoM) values were extracted from the database along with risk results, smoking status and relevant demographic information.
Results:
Smoking led to significantly reduced median levels of first trimester PAPP-A (0.89 MoM) and hCG (0.80 MoM), reduced second trimester uE3 (0.96 MoM) and hCG (0.84 MoM), and increased AFP (1.03 MoM) and inhA (1.39 MoM). After accounting for the differences in age between groups, smokers had higher Down syndrome screen positive rates for the second trimester quadruple test, but not for first trimester combined or integrated tests. Screen positive rates for trisomy 18 were markedly increased in smokers relative to age-matched non-smokers when using first trimester combined or integrated tests.
Conclusion:
Smoking leads to increased screen positive rates, especially for trisomy 18 using combined or integrated tests.
Related Concept Videos
Development of the Oral Microbiota
Teratogenicity
Stress Prevention and Stress Management Techniques IV
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
